Estrogen-related Receptor α and Estrogen-related Receptor γ Associate with Unfavorable and Favorable Biomarkers, Respectively, in Human Breast Cancer
暂无分享,去创建一个
[1] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[2] M. Kraus,et al. Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms. , 1987, The EMBO journal.
[3] W. McGuire,et al. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens , 1988, Cancer.
[4] R. Evans,et al. Identification of a new class of steroid hormone receptors , 1988, Nature.
[5] D. Barnes,et al. Expression of the ERBB3 gene product in breast cancer. , 1992, British Journal of Cancer.
[6] J G Klijn,et al. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.
[7] J. Cairns,et al. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. , 1992, British Journal of Cancer.
[8] W. McGuire,et al. Immunohistochemistry on Histological Sections from Small (50 mg) Samples of Pulverized Breast Cancer , 1993 .
[9] N. Lemoine,et al. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study. , 1994, European journal of cancer.
[10] N. Hynes,et al. The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.
[11] C. Kao,et al. Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection. , 1995, Carcinogenesis.
[12] C. Teng,et al. Estrogen-related Receptor, hERR1, Modulates Estrogen Receptor-mediated Response of Human Lactoferrin Gene Promoter (*) , 1996, The Journal of Biological Chemistry.
[13] Y. Yarden,et al. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. , 1996, The American journal of pathology.
[14] R. Kraus,et al. Estrogen-related receptor alpha 1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. , 1997, Molecular endocrinology.
[15] J. Rossant,et al. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-β , 1997, Nature.
[16] C. Teng,et al. Human estrogen receptor-like 1 (ESRL1) gene: genomic organization, chromosomal localization, and promoter characterization. , 1997, Genomics.
[17] The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. , 1997, Molecular and cellular biology.
[18] I. Ellis,et al. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer , 1998, Oncogene.
[19] Shiuan Chen,et al. Modulation of Aromatase Expression in the Breast Tissue by ERRα-1 Orphan Receptor , 1998 .
[20] V. Laudet,et al. Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[21] S. Martino,et al. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[22] C. Yang,et al. Two organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor alpha-1 orphan receptor. , 1999, Cancer research.
[23] Helmut Dotzlaw,et al. Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. , 1999, Cancer research.
[24] R. Evans,et al. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. , 1999, Molecular endocrinology.
[25] D. Miles,et al. Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer , 1999, British Journal of Cancer.
[26] J. Gustafsson,et al. Transcriptional targets shared by estrogen receptor‐related receptors (ERRs) and estrogen receptor (ER) α, but not by ERβ , 1999 .
[27] M. Stallcup,et al. Hormone-independent Transcriptional Activation and Coactivator Binding by Novel Orphan Nuclear Receptor ERR3* , 1999, The Journal of Biological Chemistry.
[28] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.
[29] M. Sliwkowski,et al. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). , 1999, Seminars in oncology.
[30] T. Mcdonald,et al. Identification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCR. , 1999, Gene.
[31] J. Russo,et al. Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer , 2000 .
[32] C. Benz,et al. Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] I. Ellis,et al. c-erbB-4 protein expression in human breast cancer , 2000, British Journal of Cancer.
[34] V. Speirs,et al. Prognostic significance of oestrogen receptor β in breast cancer , 2000 .
[35] D. J. Heard,et al. Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. , 2000, Molecular endocrinology.
[36] C. Teng,et al. Estrogen Receptor-related Receptor α1 Interacts with Coactivator and Constitutively Activates the Estrogen Response Elements of the Human Lactoferrin Gene* , 2000, The Journal of Biological Chemistry.
[37] Y. Yarden,et al. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. , 2000, Advances in cancer research.
[38] S. Bustin. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.
[39] Jorma Isola,et al. Estrogen Receptor β Is Coexpressed with ERα and PR and Associated with Nodal Status, Grade, and Proliferation Rate in Breast Cancer , 2000 .
[40] T. Fleming,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[41] M. Dowsett,et al. HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer. , 2001, Cancer research.
[42] Shiuan Chen,et al. Molecular Basis for the Constitutive Activity of Estrogen-related Receptor α-1* , 2001, The Journal of Biological Chemistry.
[43] R. Coombes,et al. Estrogen receptors and proliferation markers in primary and recurrent breast cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] Monilola A. Olayioye,et al. Update on HER-2 as a target for cancer therapy: Intracellular signaling pathways of ErbB2/HER-2 and family members , 2001, Breast Cancer Research.
[45] K. Lee,et al. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. , 2001, Cancer research.
[46] J. Rossant,et al. Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta. , 2001, Genes & development.
[47] R. Bianco,et al. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. , 2001, Cancer research.
[48] V. Giguère,et al. 4-Hydroxytamoxifen Is an Isoform-Specific Inhibitor of Orphan Estrogen-Receptor-Related (ERR) Nuclear Receptors β and γ. , 2001, Endocrinology.
[49] J. Lehmann,et al. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[50] D. Moras,et al. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. , 2002, Molecular cell.
[51] John H. White,et al. Diversity in the mechanisms of gene regulation by estrogen receptors. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[52] M. Campiglio,et al. Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[53] J. Nesland,et al. EGFR family expression in breast carcinomas. c‐erbB‐2 and c‐erbB‐4 receptors have different effects on survival , 2002, The Journal of pathology.
[54] E. Ariazi,et al. Estrogen-related Receptor α1 Actively Antagonizes Estrogen Receptor-regulated Transcription in MCF-7 Mammary Cells* , 2002, The Journal of Biological Chemistry.
[55] Ahmedin Jemal,et al. Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.
[56] Lyndsay N Harris,et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] Teri Oldaker,et al. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients , 1993, Breast Cancer Research and Treatment.